HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction
Clinical trial NCT03046914 · UNKNOWN
Trial details
- NCT number
- NCT03046914
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-24
- Primary completion
- 2017-11-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.